ResultsIQ

ResultsIQ › Latest results › Shree Ganesh Remedies Limited

Shree Ganesh Remedies Limited Q2 FY26 results deck summary

NSE: SGRL · BSE: 540737

Results deck of 7 Nov 2025, summarised by AI from the filing.

Q2 FY26 revenue ₹30.32 cr, down 6% YoY but up 23% QoQ; EBITDA margin 31.7%.

Key takeaways

  1. Q2 FY26 revenue Revenue from operations ₹30.32 cr (Q2 FY25: ₹32.33 cr, -6%; Q1 FY26: ₹24.67 cr, +23%).
  2. Margin risk Margins moderated with repricing of contracts within the CRAMS business.

Original filing on BSE

Shree Ganesh Remedies Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.